DCP2 and ovarian cancer: The flat panel cloning method visually shows that the number of clonogenic cells from ovarian cancer cells knocked down by DCP2 is smaller than that of the control group, while the clonogenic ability of cells knocked down by NUDT16 is diminished (Figures 8C, D).